SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-009606
Filing Date
2023-03-30
Accepted
2023-03-30 08:50:15
Documents
14
Period of Report
2023-03-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 fom8-k.htm   iXBRL 8-K 41814
2 ex99-1.htm EX-99.1 13610
3 ex99-1_001.jpg GRAPHIC 5572
  Complete submission text file 0001493152-23-009606.txt   244167

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aim-20230328.xsd EX-101.SCH 3227
5 XBRL LABEL FILE aim-20230328_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE aim-20230328_pre.xml EX-101.PRE 22790
8 EXTRACTED XBRL INSTANCE DOCUMENT fom8-k_htm.xml XML 3655
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 23777349
SIC: 2836 Biological Products, (No Diagnostic Substances)